Skip to Main Content

Author Details

Steve E Kalloger
University of British Columbia
2000
117
51
PMIDPaper TitleJournal TitlePublished Year
36180762Mapping the experiences of people with advanced cancer across multiple cancer types-a scoping review.J Cancer Surviv2024
36765644Classification of Pancreatic Ductal Adenocarcinoma Using MALDI Mass Spectrometry Imaging Combined with Neural Networks.Cancers (Basel)2023
37701987Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells.J Cell Sci2023
36982943Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study.Int J Mol Sci2023
36209277Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma.Nat Commun2022
32955725Stroma vs epithelium-enhanced prognostics through histologic stratification in pancreatic ductal adenocarcinoma.Int J Cancer2021
33797756Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencing.J Pathol2021
34644566Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms.Cell Rep2021
34658620Advancing the Care of Pancreatic Cancer Patients: Moving Beyond Just Tumour Tissue.Biomark Insights2021
33372414Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma.Cancer Med2021
33051307Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics.Clin Cancer Res2021
33330964Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver study.Virchows Arch2021
32958704Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?Clin Cancer Res2021
31481506Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer.Clin Cancer Res2020
32338425Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication.Health Expect2020
32413172Loss of switch/sucrose non-fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas.Histopathology2020
32518206Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer Types.Mol Cancer Ther2020
32255556Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.Cancer Med2020
31241559Immunohistochemistry Critical Assay Performance Controls (ICAPC) Reduce Interobserver Variability in the Interpretation of BRAFV600E Immunohistochemistry.Appl Immunohistochem Mol Morphol2020
31078621Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.Gastroenterology2019
31407474Mitochondrial DNA somatic mutation burden and heteroplasmy are associated with chronological age, smoking, and HIV infection.Aging Cell2019
30840638Dynamics of leukocyte telomere length in pregnant women living with HIV, and HIV-negative pregnant women: A longitudinal observational study.PLoS One2019
30833417Base excision repair deficiency signatures implicate germline and somatic <i>MUTYH</i> aberrations in pancreatic ductal adenocarcinoma and breast cancer oncogenesis.Cold Spring Harb Mol Case Stud2019
29092957Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing.Cold Spring Harb Mol Case Stud2018
32913994Temporal Dynamics of Genomic Alterations in a <i>BRCA1</i> Germline-Mutated Pancreatic Cancer With Low Genomic Instability Burden but Exceptional Response to Fluorouracil, Oxaliplatin, Leucovorin, and Irinotecan.JCO Precis Oncol2018
29930979siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth.Cell Mol Gastroenterol Hepatol2018
29796360Increased Cancer Risk in Younger Patients with Thyroid Nodules Diagnosed as Atypia of Undetermined Significance.Cureus2018
28870260Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma.BMC Cancer2017
28770102A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine.J Pathol Clin Res2017
27096160Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect Correction.PLoS One2016
26500334Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups.J Clin Pathol2016
27591097Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non-small Cell Lung Cancer.J Histochem Cytochem2016
27428735Classification of Extraovarian Implants in Patients With Ovarian Serous Borderline Tumors (Tumors of Low Malignant Potential) Based on Clinical Outcome.Am J Surg Pathol2016
27182968Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer.Nat Genet2016
25634751Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma.Am J Surg Pathol2015
26384299Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis.Oncotarget2015
26378042HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer.Oncotarget2015
26501191Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids.Nat Med2015
26339900Gastrointestinal Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy Specimens: Adequate Diagnostic Yield and Accuracy Can Be Achieved without On-Site Evaluation.Acta Cytol2015
26226846Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma.Mod Pathol2015
23887303ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas.Mod Pathol2014
25222166Determinants of quality of life in ovarian cancer survivors: a pilot study.J Obstet Gynaecol Can2014
25357111HER2/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variation.Arch Pathol Lab Med2014
24767857ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts.Hum Pathol2014
24792232Expression of matrix metalloproteinase-1 in alveolar macrophages, type II pneumocytes, and airways in smokers: relationship to lung function and emphysema.Lung2014
24559118A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.BMC Cancer2014
22899400Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.J Pathol2013
24845429Specimen quality evaluation in Canadian biobanks participating in the COEUR repository.Biopreserv Biobank2013
24376535Markers of T cell infiltration and function associate with favorable outcome in vascularized high-grade serous ovarian carcinoma.PLoS One2013
24071867Stage II to IV low-grade serous carcinoma of the ovary is associated with a poor prognosis: a clinicopathologic study of 32 patients from a population-based tumor registry.Int J Gynecol Pathol2013
  • 1 - 50 of 117

Recommended Authors

Amy Lum
University of British Columbia
Career Start Year 2014
Number of shared co-authors 41
Mich??le Orain
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Career Start Year 2013
Number of shared co-authors 6
Jenny Lester
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 2012
Number of shared co-authors 31
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 6
Chen Wang
Center for Individualized Medicine, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 27
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 4
Myriam Kossai
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 0
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
Anna M Piskorz
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2007
Number of shared co-authors 31
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 31
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 28
Jennifer B Permuth
Moffitt Cancer Center
Career Start Year 2004
Number of shared co-authors 20
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 8
Karin Jirstr??m
Lund University
Career Start Year 2003
Number of shared co-authors 1
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 1
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 16
Nadia Traficante
Peter MacCallum Cancer Centre
Career Start Year 2002
Number of shared co-authors 29
Catherine J Kennedy
The Westmead Institute for Medical Research, University of Sydney
Career Start Year 2000
Number of shared co-authors 30
Douglas A Levine
Perlmutter Cancer Center
Career Start Year 1999
Number of shared co-authors 38
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 1
Paulette Mhawech-Fauceglia
University of Southern California
Career Start Year 1995
Number of shared co-authors 3
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Naveena Singh
Barts Health NHS Trust
Career Start Year 1993
Number of shared co-authors 37
Sandra Orsulic
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 1992
Number of shared co-authors 31
Kathleen M Darcy
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 17
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 1
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Career Start Year 1981
Number of shared co-authors 35
Ronny Drapkin
University of Pennsylvania School of Medicine
Career Start Year 1980
Number of shared co-authors 20
David L Rimm
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 4
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 2

Collaborators

Cyril B Gilks
University of British Columbia
Co-authored papers 54
David G Huntsman
University of British Columbia
Co-authored papers 44
Martin K??bel
University of Calgary
Co-authored papers 30
Marco A Marra
University of British Columbia
Co-authored papers 17
Steven J M Jones
University of British Columbia
Co-authored papers 15
Michael S Anglesio
University of British Columbia
Co-authored papers 13
Blaise A Clarke
University of Toronto.
Co-authored papers 13
Leah M Prentice
British Columbia Women's Hospital and Health Centre
Co-authored papers 11
Andrew J Mungall
Co-authored papers 11
Janine Senz
University of British Columbia
Co-authored papers 11
Janessa Laskin
Co-authored papers 11
Richard A Moore
Co-authored papers 10
Sohrab P Shah
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 8
Samuel Leung
University of British Columbia
Co-authored papers 6
Samuel Aparicio
University of British Columbia
Co-authored papers 6
Kasmintan A Schrader
University of British Columbia
Co-authored papers 6
Robert E Denroche
Ontario Institute for Cancer Research
Co-authored papers 5
Gun Ho Jang
Ontario Institute for Cancer Research
Co-authored papers 5
Faiyaz Notta
2Ontario Institute for Cancer Research
Co-authored papers 4
Stefan Kommoss
Eberhard Karls University Tubingen
Co-authored papers 4
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 4
Martin R Jones
BC Cancer Research Centre.
Co-authored papers 4
Martin Hirst
University of British Columbia
Co-authored papers 3
Patricia A Shaw
Princess Margaret Cancer Centre, University Avenue
Co-authored papers 3
Alireza Heravi-Moussavi
Ferdowsi University of Mashhad
Co-authored papers 3
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 3
Ghassan Allo
Henry Ford Hospital
Co-authored papers 3
Ali Bashashati
University of British Columbia
Co-authored papers 3
Aaron Pollett
Mount Sinai Hospital
Co-authored papers 3
Release 1.2